CEL-SCI CORPORATION Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CEL-SCI CORPORATION stock issued during period, value, other for the quarter ending 2019-12-31 was $25.00K.
- CEL-SCI CORPORATION stock issued during period, value, other for the quarter ending 2019-03-31 was $1.29M, a 3.42% increase year-over-year.
- CEL-SCI CORPORATION stock issued during period, value, other for the quarter ending 2018-12-31 was $0.00.
- CEL-SCI CORPORATION stock issued during period, value, other for the quarter ending 2018-09-30 was $2.55M, a 94.60% increase year-over-year.
- CEL-SCI CORPORATION stock issued during period, value, other for fiscal 2019 was $3.40M, a 38.26% decline from fiscal 2018.
- CEL-SCI CORPORATION stock issued during period, value, other for fiscal 2018 was $5.51M, a 320.28% increase from fiscal 2017.
- CEL-SCI CORPORATION stock issued during period, value, other for fiscal 2017 was $1.31M.
- CEL-SCI CORPORATION stock issued during period, value, other for fiscal 2016 was $0.00.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2019-12-31 | $25.00K 10-Q · filed 2021-05-17 | |
| 2019-09-30 | $3.40M 10-K/A · filed 2019-12-23 | |
| 2019-03-31 | $1.29M 10-Q/A · filed 2020-12-30 | $5.55M derived: sum of 4 quarters · filed 2020-12-30 |
| 2018-12-31 | $0.00 10-Q/A · filed 2020-12-30 | $5.51M derived: sum of 4 quarters · filed 2020-12-30 |
| 2018-09-30 | $2.55M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-12-23 | $5.51M 10-K/A · filed 2019-12-23 |
| 2018-06-30 | $1.71M 10-Q · filed 2019-08-14 | |
| 2018-03-31 | $1.25M 10-Q · filed 2019-08-14 | |
| 2017-09-30 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-19 | $1.31M 10-K · filed 2018-12-19 |
| 2017-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-14 | |
| 2016-09-30 | $0.00 10-K · filed 2017-12-29 | |
| 2014-09-30 | $10.00K 10-K/A · filed 2017-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |